Global Pharmaceuticals & Biotech Most Popular Stocks

Physiomics

Market Cap: UK£1.5m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Chemo Pharma Laboratories

Market Cap: ₹171.0m

Does not have significant operations.

Nascent Pharma Holdings

Market Cap: US$1.9m

Engages in the protection and commercialization of cannabis patents.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Emmessar Biotech & Nutrition

Market Cap: ₹169.6m

A healthcare company, provides healthcare and nutritional products in India and internationally.

BioSenic

Market Cap: €1.6m

A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.

Cronex.Co.Ltd

Market Cap: ₩2.7b

Engages in the research and development of medicines and raw materials for medical research.

Norris Medicines

Market Cap: ₹166.0m

Manufactures and sells pharmaceutical formulations in India.

AXIM Biotechnologies

Market Cap: US$1.8m

Develops diagnostic healthcare solutions for ophthalmological conditions.

Breakthrough Chemistry

Market Cap: US$1.8m

Develops compounds and formulations that defy the norms prevalent in chemical industries.

Cai Lay Veterinary Pharmaceutical

Market Cap: ₫48.5b

Manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina.

Restart Life Sciences

Market Cap: CA$2.5m

Through its subsidiaries, operates as a biotechnology company worldwide.

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

Stayble Therapeutics

Market Cap: SEK 17.0m

Develops injectable treatment for chronic pain triggered by disc degeneration.

Agentix

Market Cap: US$1.8m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

HBL - Hadasit Bio-Holdings

Market Cap: ₪6.1m

Operates in the biotechnology industry in Israel.

OMID Holdings

Market Cap: US$1.8m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

Psyence Biomedical

Market Cap: US$1.8m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

Appili Therapeutics

Market Cap: CA$2.4m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

CBD Life Sciences

Market Cap: US$1.7m

Engages in the development and marketing a line of cannabidiol based organic products.

Vanta Bioscience

Market Cap: ₹153.1m

Operates as a preclinical contract research organization in India.

Algernon Pharmaceuticals

Market Cap: CA$2.4m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

Evofem Biosciences

Market Cap: US$1.7m

A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

Longevity Health Holdings

Market Cap: US$1.6m

A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.

GeNeuro

Market Cap: €1.4m

A clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases.

Labocanna

Market Cap: zł5.8m

Engages in the cultivation, production, and distribution of hemp product.

Psyence Group

Market Cap: CA$2.2m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

LiveCare

Market Cap: US$1.5m

Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

Endexx

Market Cap: US$1.5m

Develops and sells hemp-derived products for the health and wellness market under the CBD Unlimited brand in the United States and internationally.

Nidhogg Resources Holding

Market Cap: SEK 14.2m

Operates in the natural resources sector primarily in Sweden.

AdAlta

Market Cap: AU$2.3m

A clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.

Body and Mind

Market Cap: US$1.5m

Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, Illinois, and New Jersey in the United States.

Vaccinex

Market Cap: US$1.5m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.